Mineralys Therapeutics, Inc. (MLYS) announced the appointment of Kristine Peterson and Lonnel Coats to its Board of Directors, effective October 19, 2026. The appointments expand the company's board from seven to nine members.
Key Details
- Appointments: Kristine Peterson was appointed as a Class I director and will serve on the Audit Committee. Lonnel Coats was appointed as a Class II director and will serve on the Compensation Committee.
- Equity Compensation: As part of their compensation, each new director was granted an option to purchase 16,600 shares and a restricted stock unit (RSU) award covering 12,400 shares. Both grants vest over a three-year period.
- Board Expansion: The addition of Ms. Peterson and Mr. Coats, who are both independent directors, increases the total number of directors on the MLYS board from seven to nine.